Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Primary sclerosing cholangitis is a premalignant condition].

C Schramm1, P R Galle

  • 1Medizinische Klinik I, Universitätsklinikum Hamburg-Eppendorf.

Zeitschrift Fur Gastroenterologie
|June 30, 2005
PubMed
Summary

Primary sclerosing cholangitis (PSC) is a progressive liver disease that significantly increases cancer risk. This review examines cholangiocarcinoma development in PSC patients, focusing on diagnosis and treatment challenges.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary sclerosing cholangitis: Time to rethink imaging criteria for early disease detection.

Journal of hepatology·2026
Same author

Trends in Primary Biliary Cholangitis: Prospective Cohort Study From the European Reference Network Registry (R-LIVER).

United European gastroenterology journal·2025
Same author

Health-related quality of life analysis of the LEAP-002 study of lenvatinib plus pembrolizumab versus lenvatinib as first-line treatment for advanced hepatocellular carcinoma.

ESMO open·2025
Same author

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

What contribution can genetics make to predict the risk of Alzheimer's disease?

Revue neurologique·2022
Same author

Present and future role of endoscopic retrograde cholangiography in primary sclerosing cholangitis.

European journal of medical genetics·2021

Area of Science:

  • Hepatology and Gastroenterology
  • Oncology
  • Chronic Disease Epidemiology

Context:

  • Primary sclerosing cholangitis (PSC) is a rare, chronic liver disease with unknown causes.
  • PSC is characterized by progressive bile duct inflammation and fibrosis, often leading to cirrhosis.
  • Patients with PSC have a substantially elevated risk of developing hepatobiliary malignancies and colorectal cancer.

Purpose:

  • To review the development of cholangiocellular carcinoma (CCA) in patients with PSC.
  • To discuss the diagnostic challenges associated with CCA in the context of PSC.
  • To outline current and potential therapeutic strategies for CCA in PSC patients.

Summary:

  • PSC is a premalignant condition due to its association with increased cancer risk.
  • Cholangiocarcinoma is a significant concern for PSC patients, necessitating early detection.
  • Effective management requires addressing both the underlying PSC and the emergent CCA.

Impact:

  • Highlights PSC as a critical risk factor for cholangiocarcinoma.
  • Emphasizes the need for improved diagnostic tools and surveillance in PSC patients.
  • Informs clinical practice regarding the management of PSC-associated malignancies.

Related Experiment Videos